0       0

HFSA's 19th Annual Scientific Meeting


Pharmacogenetics of Heart Failure and Transplant: Additive or redundant?


Sep 29, 2015 10:15am ‐ Sep 29, 2015 11:30am

Description

Describe the relationship between pharmacogenetics and heart failure and transplantation and identify potential next steps.

Speaker Objective(s):

  • Pharmacogenetics : Overview and Clinical Status
  • Pharmacogenetics of Beta Blockers : Still Relevant?
  • Optimizing Use of Hydralazine and Isosorbide Dinitrate: What is the Evidence?
  • Genetic Contribution of Immunosuppression-Related Toxicity: Better than Serum Drug Concentration Monitoring?
  • Barriers to Implementation in Practice: Current State of the Art
  • Chest Risk for Non-Recovery

Moderator(s):

  • Michael Bristow, MD, PhD, Professor of Medicine (Cardiology), University of Colorado, Aurora AMC and Boulder
  • Arthur Feldman, MD, Temple University

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content